−50 KRW
−2.51 B KRW
370.54 B KRW
11.40 M
About ILYANG PHARMACEUTICAL
Sector
Headquarters
Yongin-si
Founded
1946
Website
ISIN
KR7007570005
FIGI
BBG000BDMPJ8
Ilyang Pharmaceutical Co., Ltd. engages in the manufacture, development, and distribution of pharmaceutical drugs. The firm's products include medicine, food, cosmetic, and antacid raw materials. It operates through the following business divisions: Ilyang Pharmaceutical, Yangju Ilyang, Ilyang Biopharm, and Cantech. The Ilyang Pharmaceutical business division offers prescription drugs, over-the-counter (OTC) medicine, health supplements, and export of raw drug products. The Yangju Ilyang business division refers to antacids prescription drugs. The Ilyang Biopharma business division pertains to anti-inflammatory drugs. The Cantech business division consists of the BizXR ERP trademark. The company was founded on July 1, 1946 and is headquartered in Yongin-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 007570 is 10,960 KRW — it has increased by 0.92% in the past 24 hours. Watch ILYANG PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ILYANG PHARMACEUTICAL stocks are traded under the ticker 007570.
007570 stock has risen by 3.40% compared to the previous week, the month change is a −1.26% fall, over the last year ILYANG PHARMACEUTICAL has showed a −28.88% decrease.
007570 reached its all-time high on Jul 21, 2020 with the price of 106,500 KRW, and its all-time low was 1,340 KRW and was reached on Jun 23, 2004. View more price dynamics on 007570 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
007570 stock is 3.10% volatile and has beta coefficient of 0.57. Track ILYANG PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is ILYANG PHARMACEUTICAL there?
Today ILYANG PHARMACEUTICAL has the market capitalization of 196.98 B, it has increased by 4.24% over the last week.
Yes, you can track ILYANG PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
007570 net income for the last quarter is 3.45 B KRW, while the quarter before that showed 1.09 B KRW of net income which accounts for 218.04% change. Track more ILYANG PHARMACEUTICAL financial stats to get the full picture.
Yes, 007570 dividends are paid annually. The last dividend per share was 150.00 KRW. As of today, Dividend Yield (TTM)% is 1.37%. Tracking ILYANG PHARMACEUTICAL dividends might help you take more informed decisions.
As of Dec 21, 2024, the company has 641.00 employees. See our rating of the largest employees — is ILYANG PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ILYANG PHARMACEUTICAL EBITDA is 27.63 B KRW, and current EBITDA margin is 8.96%. See more stats in ILYANG PHARMACEUTICAL financial statements.
Like other stocks, 007570 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ILYANG PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ILYANG PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ILYANG PHARMACEUTICAL stock shows the sell signal. See more of ILYANG PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.